FindTrial
Sign In

Expanded Access for CC-4047

Expanded Access for CC-4047

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT03723096
Enrollment
Unknown
Registered
2018-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2018-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Myeloma

Keywords

Expanded Access, Compassionate Use

Brief summary

This is an expanded access program (EAP) for eligible participants designed to provide access to CC-4047.

Interventions

DRUGCC-4047

CC-4047 will be administered orally

Sponsors

Celgene
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL

Inclusion criteria

\-

Exclusion criteria

\-

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026